The registry was created to monitor all patients with juvenile idiopathic arthritis (JIA) in cooperation with patients and care providers to increase the quality of care and improve health and quality of life for the patients. The primary goal is to follow all patients with JIA treated with biologic agents. The secondary goal is to follow all patients with JIA regardless of therapy.
Patients 0-17 years of age with juvenile idiopathic arthritis in Sweden.
To some extent, patients with other paediatric rheumatic diseases.
Ages 0-17 (up to age 18).
2600 patients (2000 active).
60 percent of all JIA (active and inactive disease). Over 90 percent of biological therapy for JIA. All care providers for JIA in Sweden participate.
Note: Variable lists are updated on a regular basis and should therefore be seen as preliminary. For the latest version, please contact the registry.
Category: Paediatrics, obstetrics and gynaecology
Certification level: 2
Tack för att du hjälper oss!